Answer
Belantamab mafodotin (Blenrep) is contraindicated in patients with hypersensitivity to belantamab mafodotin or any excipient listed in section 6.1 of its product information.
Sources for this answer
- Blenrep 100mg & 70 mg powder for concentrate for solution for infusionGlaxoSmithKline UK · emc · SmPC §4.3 Contraindications · Version 2Document updated
Sources checked